HOXA5-twist interaction alters p53 homeostasis in breast cancer cells
- PMID: 15545268
- DOI: 10.1074/jbc.M411018200
HOXA5-twist interaction alters p53 homeostasis in breast cancer cells
Abstract
The homeotic gene HOXA5 has been shown to play an important role in breast tumorigenesis. We have shown that loss of p53 correlated with loss of a developmentally regulated transcription factor, HOXA5, in primary breast cancer. Searching for potential protein interacting partners we found that HOXA5 binds to an anti-apoptotic protein, Twist. Furthermore, Twist-overexpressing MCF-7 cells displayed a deregulated p53 response to gamma-radiation and decreased regulation of downstream target genes. Using a p53-promoter-reporter system, we demonstrated that HOXA5 could partially restore the inhibitory effects of Twist on p53 target genes. These effects are likely mediated through both the transcriptional up-regulation of p53 and the protein-protein interaction between HOXA5 and Twist. Thus, the loss of HOXA5 expression could lead to the functional activation of Twist resulting in aberrant cell cycle regulation and promoting breast carcinogenesis.
Similar articles
-
HOXA5 regulates hMLH1 expression in breast cancer cells.Neoplasia. 2006 Apr;8(4):250-8. doi: 10.1593/neo.05766. Neoplasia. 2006. PMID: 16756717 Free PMC article.
-
HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8.Mol Cell Biol. 2004 Jan;24(2):924-35. doi: 10.1128/MCB.24.2.924-935.2004. Mol Cell Biol. 2004. PMID: 14701762 Free PMC article.
-
Identification of transcriptional targets of HOXA5.J Biol Chem. 2005 May 13;280(19):19373-80. doi: 10.1074/jbc.M413528200. Epub 2005 Mar 9. J Biol Chem. 2005. PMID: 15757903
-
Compromised HOXA5 function can limit p53 expression in human breast tumours.Nature. 2000 Jun 22;405(6789):974-8. doi: 10.1038/35016125. Nature. 2000. PMID: 10879542
-
HOXA5: A crucial transcriptional factor in cancer and a potential therapeutic target.Biomed Pharmacother. 2022 Nov;155:113800. doi: 10.1016/j.biopha.2022.113800. Epub 2022 Oct 8. Biomed Pharmacother. 2022. PMID: 36271576 Review.
Cited by
-
Deregulation of miR-375 Inhibits HOXA5 and Promotes Migration, Invasion, and Cell Proliferation in Breast Cancer.Appl Biochem Biotechnol. 2023 Jul;195(7):4503-4523. doi: 10.1007/s12010-023-04375-3. Epub 2023 Jan 26. Appl Biochem Biotechnol. 2023. PMID: 36701095
-
T cell exhaustion assessment algorism in tumor microenvironment predicted clinical outcomes and immunotherapy effects in glioma.Front Genet. 2022 Dec 2;13:1087434. doi: 10.3389/fgene.2022.1087434. eCollection 2022. Front Genet. 2022. PMID: 36531217 Free PMC article.
-
HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells.Cancer Res. 2022 Oct 17;82(20):3802-3814. doi: 10.1158/0008-5472.CAN-21-4277. Cancer Res. 2022. PMID: 36166646 Free PMC article.
-
Twist alters the breast tumor microenvironment via choline kinase to facilitate an aggressive phenotype.Mol Cell Biochem. 2023 Apr;478(4):939-948. doi: 10.1007/s11010-022-04555-5. Epub 2022 Sep 22. Mol Cell Biochem. 2023. PMID: 36136285
-
Diagnostic and Therapeutic Perspectives Associated to Cobalamin-Dependent Metabolism and Transcobalamins' Synthesis in Solid Cancers.Nutrients. 2022 May 14;14(10):2058. doi: 10.3390/nu14102058. Nutrients. 2022. PMID: 35631199 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
